BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35265542)

  • 21. Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.
    Shin SY; Lee ST; Kim HY; Park CH; Kim HJ; Kim JW; Kim SJ; Kim WS; Kim SH
    Blood Res; 2016 Sep; 51(3):181-186. PubMed ID: 27722129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of bone marrow core biopsy patterns in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia and description of its mutational profiles by targeted NGS.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez de Villambrosia S; Gomez Mediavilla A; Urquieta Lam M; Insunza A; Tonda R; Beltran S; Gut M; Gonzalez A; Montes-Moreno S
    J Clin Pathol; 2020 Sep; 73(9):571-577. PubMed ID: 31980558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis.
    García-Abellás P; Ferrer Gómez A; Bueno Sacristán D; Piris Villaespesa M; Talavera Yagüe M; Reguero Callejas ME; García-Cosío M
    EJHaem; 2022 Nov; 3(4):1181-1187. PubMed ID: 36467836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis.
    Rossi D
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):113-8. PubMed ID: 25696843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lymphoplasmacytic lymphoma: a clinicopathological and prognostic analysis of 27 cases].
    Chen Y; Zhang F; Wu HM; Luo XL; Zhang KP; Liu YH
    Zhonghua Bing Li Xue Za Zhi; 2021 Dec; 50(12):1346-1352. PubMed ID: 34865422
    [No Abstract]   [Full Text] [Related]  

  • 28. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
    Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients.
    Lin P; Hao S; Handy BC; Bueso-Ramos CE; Medeiros LJ
    Am J Clin Pathol; 2005 Feb; 123(2):200-5. PubMed ID: 15842043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells.
    Ouk C; Roland L; Gachard N; Poulain S; Oblet C; Rizzo D; Saintamand A; Lemasson Q; Carrion C; Thomas M; Balabanian K; Espéli M; Parrens M; Soubeyran I; Boulin M; Faumont N; Feuillard J; Vincent-Fabert C
    Front Immunol; 2021; 12():641692. PubMed ID: 34017329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
    Brandefors L; Sander B; Lundqvist K; Kimby E
    Br J Haematol; 2022 Mar; 196(6):1362-1368. PubMed ID: 34959252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
    Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
    Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia].
    Timár B
    Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection.
    Kapoor P; Paludo J; Ansell SM
    Curr Treat Options Oncol; 2016 Mar; 17(3):16. PubMed ID: 26942591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endomyocardial biopsy with co-localization of a lymphoplasmacytic lymphoma and AL amyloidosis.
    Leguit RJ; Vink A; de Jonge N; Minnema MC; Oerlemans MIF
    Cardiovasc Pathol; 2021; 53():107348. PubMed ID: 34038803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
    Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
    Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
    Naderi N; Yang DT
    Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.
    Patkar N; Subramanian PG; Deshpande P; Ghodke K; Tembhare P; Mascarenhas R; Muranjan A; Chaudhary S; Bagal B; Gujral S; Sengar M; Menon H
    Leuk Lymphoma; 2015 Feb; 56(2):420-5. PubMed ID: 24828863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
    Fang H; Kapoor P; Gonsalves WI; Frederick LA; Viswanatha D; Howard MT; He R; Morice WG; McPhail ED; Greipp PT; Ansell SM; Kyle RA; Gertz MA; Paludo J; Abeykoon J; King RL
    Am J Clin Pathol; 2018 Jul; 150(2):168-176. PubMed ID: 29868855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.